Selected research
Industry Growth & Trends
Global Animal Pharmaceutical Industry Growth and Trends Forecast to 2032
Market perspective
The global Animal Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Animal Pharmaceutical include Merck, Zoetis, Virbac, Vétoquinol, Ringpu Biology, PARNELL, MSD Animal Health Australia, Merial and Jurox, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Animal Pharmaceutical market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Animal Pharmaceutical market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal Pharmaceutical market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal Pharmaceutical.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Animal Pharmaceutical market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Animal Pharmaceutical Market by Company
Merck
Zoetis
Virbac
Vétoquinol
Ringpu Biology
PARNELL
MSD Animal Health Australia
Merial
Jurox
Elanco
Ceva Sante Animale
CAHIC
Boehringer Ingelheim Vetmedica
Bayer Animal Health
Animal Pharmaceutical Segment by Type
Vaccine
Veterinary Drugs
Other
Animal Pharmaceutical Segment by Application
Companion Animal
Poultry
Other
Animal Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Animal Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccine
- Veterinary Drugs
- Other
Applications
- Companion Animal
- Poultry
- Other
Companies covered
- Merck
- Zoetis
- Virbac
- Vétoquinol
- Ringpu Biology
- PARNELL
- MSD Animal Health Australia
- Merial
- Jurox
- Elanco
- Ceva Sante Animale
- CAHIC
- Boehringer Ingelheim Vetmedica
- Bayer Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Animal Pharmaceutical Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Animal Pharmaceutical Sales Estimates and Forecasts (2021-2032)
- 1.3 Animal Pharmaceutical Market by Type
- 1.3.1 Vaccine
- 1.3.2 Veterinary Drugs
- 1.3.3 Other
- 1.4 Global Animal Pharmaceutical Market Size by Type
- 1.4.1 Global Animal Pharmaceutical Market Size Overview by Type (2021-2032)
- 1.4.2 Global Animal Pharmaceutical Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Animal Pharmaceutical Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Animal Pharmaceutical Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Animal Pharmaceutical Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Animal Pharmaceutical Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Animal Pharmaceutical Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Animal Pharmaceutical Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Animal Pharmaceutical Industry Trends
- 2.2 Animal Pharmaceutical Industry Drivers
- 2.3 Animal Pharmaceutical Industry Opportunities and Challenges
- 2.4 Animal Pharmaceutical Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Animal Pharmaceutical Revenue (2021-2026)
- 3.2 Global Top Players by Animal Pharmaceutical Sales (2021-2026)
- 3.3 Global Top Players by Animal Pharmaceutical Price (2021-2026)
- 3.4 Global Animal Pharmaceutical Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Animal Pharmaceutical Major Company Production Sites & Headquarters
- 3.6 Global Animal Pharmaceutical Company, Product Type & Application
- 3.7 Global Animal Pharmaceutical Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Animal Pharmaceutical Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Animal Pharmaceutical Players Market Share by Revenue in 2025
- 3.8.3 2025 Animal Pharmaceutical Tier 1, Tier 2, and Tier 3
4 Animal Pharmaceutical Regional Status and Outlook
- 4.1 Global Animal Pharmaceutical Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Animal Pharmaceutical Historic Market Size by Region
- 4.2.1 Global Animal Pharmaceutical Sales in Volume by Region (2021-2026)
- 4.2.2 Global Animal Pharmaceutical Sales in Value by Region (2021-2026)
- 4.2.3 Global Animal Pharmaceutical Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Animal Pharmaceutical Forecasted Market Size by Region
- 4.3.1 Global Animal Pharmaceutical Sales in Volume by Region (2027-2032)
- 4.3.2 Global Animal Pharmaceutical Sales in Value by Region (2027-2032)
- 4.3.3 Global Animal Pharmaceutical Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal Pharmaceutical by Application
- 5.1 Animal Pharmaceutical Market by Application
- 5.1.1 Companion Animal
- 5.1.2 Poultry
- 5.1.3 Other
- 5.2 Global Animal Pharmaceutical Market Size by Application
- 5.2.1 Global Animal Pharmaceutical Market Size Overview by Application (2021-2032)
- 5.2.2 Global Animal Pharmaceutical Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Animal Pharmaceutical Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Animal Pharmaceutical Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Animal Pharmaceutical Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Animal Pharmaceutical Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Animal Pharmaceutical Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Animal Pharmaceutical Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Merck Animal Pharmaceutical Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Zoetis
- 6.2.1 Zoetis Company Information
- 6.2.2 Zoetis Business Overview
- 6.2.3 Zoetis Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Zoetis Animal Pharmaceutical Product Portfolio
- 6.2.5 Zoetis Recent Developments
- 6.3 Virbac
- 6.3.1 Virbac Company Information
- 6.3.2 Virbac Business Overview
- 6.3.3 Virbac Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Virbac Animal Pharmaceutical Product Portfolio
- 6.3.5 Virbac Recent Developments
- 6.4 Vétoquinol
- 6.4.1 Vétoquinol Company Information
- 6.4.2 Vétoquinol Business Overview
- 6.4.3 Vétoquinol Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Vétoquinol Animal Pharmaceutical Product Portfolio
- 6.4.5 Vétoquinol Recent Developments
- 6.5 Ringpu Biology
- 6.5.1 Ringpu Biology Company Information
- 6.5.2 Ringpu Biology Business Overview
- 6.5.3 Ringpu Biology Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
- 6.5.5 Ringpu Biology Recent Developments
- 6.6 PARNELL
- 6.6.1 PARNELL Company Information
- 6.6.2 PARNELL Business Overview
- 6.6.3 PARNELL Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 PARNELL Animal Pharmaceutical Product Portfolio
- 6.6.5 PARNELL Recent Developments
- 6.7 MSD Animal Health Australia
- 6.7.1 MSD Animal Health Australia Company Information
- 6.7.2 MSD Animal Health Australia Business Overview
- 6.7.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
- 6.7.5 MSD Animal Health Australia Recent Developments
- 6.8 Merial
- 6.8.1 Merial Company Information
- 6.8.2 Merial Business Overview
- 6.8.3 Merial Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Merial Animal Pharmaceutical Product Portfolio
- 6.8.5 Merial Recent Developments
- 6.9 Jurox
- 6.9.1 Jurox Company Information
- 6.9.2 Jurox Business Overview
- 6.9.3 Jurox Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jurox Animal Pharmaceutical Product Portfolio
- 6.9.5 Jurox Recent Developments
- 6.10 Elanco
- 6.10.1 Elanco Company Information
- 6.10.2 Elanco Business Overview
- 6.10.3 Elanco Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Elanco Animal Pharmaceutical Product Portfolio
- 6.10.5 Elanco Recent Developments
- 6.11 Ceva Sante Animale
- 6.11.1 Ceva Sante Animale Company Information
- 6.11.2 Ceva Sante Animale Business Overview
- 6.11.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
- 6.11.5 Ceva Sante Animale Recent Developments
- 6.12 CAHIC
- 6.12.1 CAHIC Company Information
- 6.12.2 CAHIC Business Overview
- 6.12.3 CAHIC Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 CAHIC Animal Pharmaceutical Product Portfolio
- 6.12.5 CAHIC Recent Developments
- 6.13 Boehringer Ingelheim Vetmedica
- 6.13.1 Boehringer Ingelheim Vetmedica Company Information
- 6.13.2 Boehringer Ingelheim Vetmedica Business Overview
- 6.13.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
- 6.13.5 Boehringer Ingelheim Vetmedica Recent Developments
- 6.14 Bayer Animal Health
- 6.14.1 Bayer Animal Health Company Information
- 6.14.2 Bayer Animal Health Business Overview
- 6.14.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
- 6.14.5 Bayer Animal Health Recent Developments
7 North America by Country
- 7.1 North America Animal Pharmaceutical Sales by Country
- 7.1.1 North America Animal Pharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Animal Pharmaceutical Sales by Country (2021-2026)
- 7.1.3 North America Animal Pharmaceutical Sales Forecast by Country (2027-2032)
- 7.2 North America Animal Pharmaceutical Market Size by Country
- 7.2.1 North America Animal Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Animal Pharmaceutical Market Size by Country (2021-2026)
- 7.2.3 North America Animal Pharmaceutical Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Animal Pharmaceutical Sales by Country
- 8.1.1 Europe Animal Pharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Animal Pharmaceutical Sales by Country (2021-2026)
- 8.1.3 Europe Animal Pharmaceutical Sales Forecast by Country (2027-2032)
- 8.2 Europe Animal Pharmaceutical Market Size by Country
- 8.2.1 Europe Animal Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Animal Pharmaceutical Market Size by Country (2021-2026)
- 8.2.3 Europe Animal Pharmaceutical Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Animal Pharmaceutical Sales by Country
- 9.1.1 Asia-Pacific Animal Pharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Animal Pharmaceutical Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Animal Pharmaceutical Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Animal Pharmaceutical Market Size by Country
- 9.2.1 Asia-Pacific Animal Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Animal Pharmaceutical Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Animal Pharmaceutical Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Animal Pharmaceutical Sales by Country
- 10.1.1 South America Animal Pharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Animal Pharmaceutical Sales by Country (2021-2026)
- 10.1.3 South America Animal Pharmaceutical Sales Forecast by Country (2027-2032)
- 10.2 South America Animal Pharmaceutical Market Size by Country
- 10.2.1 South America Animal Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Animal Pharmaceutical Market Size by Country (2021-2026)
- 10.2.3 South America Animal Pharmaceutical Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Animal Pharmaceutical Sales by Country
- 11.1.1 Middle East and Africa Animal Pharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Animal Pharmaceutical Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Animal Pharmaceutical Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Animal Pharmaceutical Market Size by Country
- 11.2.1 Middle East and Africa Animal Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Animal Pharmaceutical Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Animal Pharmaceutical Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Animal Pharmaceutical Value Chain Analysis
- 12.1.1 Animal Pharmaceutical Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Animal Pharmaceutical Production Mode & Process
- 12.2 Animal Pharmaceutical Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Animal Pharmaceutical Distributors
- 12.2.3 Animal Pharmaceutical Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst